Lannett Company
LCI
#10382
Rank
HK$57.45 M
Marketcap
HK$5.34
Share price
0.00%
Change (1 day)
-69.92%
Change (1 year)

Lannett Company (LCI) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : HK$5.81 Billion

According to Lannett Company's latest financial reports the company's total liabilities are HK$5.81 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lannett Company - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-06-30HK$5.77 B4.52%
2021-06-30HK$5.52 B-14.54%
2020-06-30HK$6.46 B-3.08%
2019-06-30HK$6.66 B-13%
2018-06-30HK$7.66 B-5.81%
2017-06-30HK$8.13 B-13.32%
2016-06-30HK$9.38 B2590.91%
2015-06-30HK$0.34 B-6.25%
2014-06-30HK$0.37 B23.18%
2013-06-30HK$0.30 B-16.99%
2012-06-30HK$0.36 B11.18%
2011-06-30HK$0.32 B-17.62%
2010-06-30HK$0.39 B9.23%
2009-06-30HK$0.36 B-1.88%
2008-06-30HK$0.37 B37.57%
2007-06-30HK$0.26 B14.73%
2006-06-30HK$0.23 B17.75%
2005-06-30HK$0.19 B23.13%
2004-06-30HK$0.16 B178.27%
2003-06-30HK$58.2 M7.49%
2002-06-30HK$54.15 M-47.21%
2001-06-30HK$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$900.17 B 15,382.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$883.85 B 15,101.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$256.24 B 4,307.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.82 B 8,273.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
HK$477.07 B 8,105.35%๐Ÿ‡ฌ๐Ÿ‡ง UK